Validation of the cantharidin-induced blister method in Complex Regional Pain Syndrome

Recruiting

• Conditions: 10003816; 10017322

• Registration Number: NL-OMON30083
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

acute or chronic CRPS

Exclusion Criteria

use of immunosuppressives

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Bioactive substances: cytokines, nitric oxide and other vasoactive mediators.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>none</p><br>